Thread by @Quo_vadis_BRD

Ein äußerst wichtiger Text:

1/ „So, in short, why is there so much focus on #Pfizer in public discussion of the Covid vaccine market, virtually to the exclusion of #BioNTech and even in discussion by seasoned financial analysts?

Indeed, why is the …

brownstone.org/articles/50-50…

2/ … product in question even called the ‚Pfizer‘ vaccine? This is obviously a misnomer. It is #BioNTech /s vaccine … . #BioNTech developed and literally owns it. Hence, its scientific codename: #BNT162b2. #Pfizer merely manufactures and sells it in certain (but not all) …

3/ … markets on #BioNTech /s behalf.

#BioNTech was also the sponsor of the famous clinical trials that led to the vaccine‘s authorization. … #Pfizer merely carried out the trials, yet again, on #BioNTech /s behalf. And #BioNTech is the marketing authorization holder on …

4/ … every market where the product is sold by #Pfizer, as well, of course, as on its own reserved markets. And, finally, #BioNTech is, as shown above, by far the principal financial beneficiary of the product‘s commercialization.

This is not just a ‚semantic‘ matter. …

5/ … We need to name things correctly to understand them correctly. The intense focus on #Pfizer, to the point of making #BioNTech virtually disappear, has, among other things, created an illusion of #Pfizer /s global power and DIVERTED ATTENTION FROM STATE ACTORS: IN …

6/ … PARTICULAR, GERMANY, WHICH, … SPONSORED THE #BIONTECH VACCINE AND HAS A MAJOR ECONOMIC INTEREST IN THE GLOBAL SUCCESS OF BOTH PRODUCT AND FIRM.

Indeed, … the German government sponsored the very founding of #BioNTech as part of a ‚Go-Bio‘ funding program whose …

7/ … express purpose was to make Germany a leader in biotechnologies.

As so happens, unbeknownst to most observers, GERMANY HAS ALSO BEEN FAR AND AWAY THE PRINICIPAL FUNDER OF THE WHO‘S VACCINE-CENTRIC GLOBAL COVID-19-RESPONSE.“
…

8/ Auch lesenswert als Hintergrund-Information:

H/t @voltaire

brownstone.org/articles/the-p…